ProQR Therapeutics N.V. (PRQR)
1.41
-0.02 (-1.40%)
At close: Mar 28, 2025, 3:59 PM
1.46
3.81%
After-hours: Mar 28, 2025, 04:28 PM EDT
ProQR Therapeutics Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Cash & Equivalents | 149.41M | 118.92M | 94.78M | 187.52M | 75.84M | 111.95M | 105.58M | 48.1M | 59.2M | 94.86M | 112.74M | 4.13M | 249K |
| Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | 621K | 629K | 107K | 429K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Receivables | 2.03M | 1.27M | 57.24M | n/a | 421K | n/a | 1.24M | n/a | 1.56M | 1.5M | 426K | 130K | 47K |
| Inventory | n/a | n/a | 6.87K | 266.45K | 379K | 340K | 899K | 73K | 1.17M | 547K | 327K | n/a | n/a |
| Other Current Assets | 2.41M | 793K | 2.45M | 3.14M | -800K | 1.53M | -2.14M | 1.99M | 1.25M | 1.4M | -753K | 2K | 3K |
| Total Current Assets | 153.84M | 120.99M | 154.46M | 191.48M | 80.02M | 114.67M | 108.37M | 50.56M | 62.02M | 97.77M | 113.9M | 4.26M | 299K |
| Property-Plant & Equipment | 14.11M | 16.9M | 16.24M | 17.47M | 18.6M | 2.44M | 1.86M | 2.5M | 3.44M | 2.2M | 1.19M | 204K | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 39K | 90K | 141K | 163K | 39K | 39K |
| Total Long-Term Assets | 14.11M | 16.9M | 16.86M | 18.1M | 18.71M | 2.87M | 1.86M | 2.54M | 3.53M | 2.34M | 1.35M | 243K | 39K |
| Total Assets | 167.96M | 137.88M | 171.32M | 209.58M | 98.73M | 117.53M | 110.23M | 53.1M | 65.54M | 100.11M | 115.25M | 4.5M | 338K |
| Account Payables | 16K | 1.54M | 392K | 191K | 221K | 445K | 135K | 546K | 328K | 885K | 1.25M | 745K | 95K |
| Deferred Revenue | 21.94M | 20.57M | 5.76M | 5.12M | 700K | 711K | 545K | 347K | n/a | 144K | 468K | 46K | n/a |
| Short-Term Debt | 6.15M | 1.61M | 3.89M | 6.3M | 2.4M | 851K | n/a | 1.96M | n/a | 15K | 34K | 2.55M | n/a |
| Other Current Liabilities | 9.32M | 8.82M | 10.07M | 14.76M | 6.96M | 8.81M | 7.48M | 4.62M | 6.07M | 4.21M | 1.39M | 279K | 45K |
| Total Current Liabilities | 38.9M | 34.2M | 21.11M | 27.6M | 10.3M | 10.99M | 8.16M | 8.49M | 6.71M | 5.49M | 3.01M | 3.6M | 143K |
| Long-Term Debt | 11.07M | 18.12M | 18.08M | 54.07M | 31.88M | 12.71M | 9.39M | 5.28M | 5.7M | 4.82M | 2.83M | 991K | 96K |
| Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Liabilities | 40.5M | 62.29M | 85.1M | 68.75M | 31.88M | 12.71M | 9.39M | 5.28M | 5.7M | 4.82M | 2.83M | 991K | 96K |
| Total Liabilities | 79.4M | 96.49M | 106.21M | 96.35M | 42.18M | 23.7M | 17.55M | 13.78M | 12.41M | 10.31M | 5.84M | 4.59M | 239K |
| Total Debt | 17.22M | 19.73M | 21.97M | 60.37M | 34.28M | 13.56M | 9.39M | 7.24M | 5.7M | 4.84M | 2.86M | 3.54M | 96K |
| Common Stock | 4.31M | 3.37M | 3.37M | 3M | 2.17M | 2.16M | 1.73M | 1.46M | 934K | 934K | 934K | 59K | 33K |
| Retained Earnings | -427.16M | -400.85M | -380.68M | -317.77M | -257.75M | -211.75M | -155.44M | -119.37M | -75.73M | -36.63M | -15.8M | -3.67M | -418K |
| Comprehensive Income | 27.6M | 25.98M | 30.26M | 30.3M | -189K | 151K | 108K | 136K | -15K | 1K | 687K | 41K | n/a |
| Shareholders Equity | 88.56M | 41.39M | 65.5M | 113.83M | 57.09M | 94.33M | 92.92M | 39.36M | 53.14M | 89.8M | 109.4M | -89K | 99K |
| Total Investments | n/a | -98.05K | 621K | 629K | 107K | 429K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |